Michael L. Poltash

Johnson & Johnson (United States)

Papers

1

Total Citations

24

H-Index

1

About

Dr. Michael L. Poltash is a pioneering researcher at the forefront of biopharmaceutical characterization, specializing in the automation of high-throughput mass spectrometry. His major contribution is the conceptualization and realization of the “Lab of the Future,” a fully automated, integrated system that revolutionizes the analysis of biotherapeutics. As detailed in his highly cited 2023 paper (24 citations), this system seamlessly combines liquid handling robotics, microplate utilities, and LC-MS instrumentation with advanced data analysis software. By automating complex, multi-step workflows, Dr. Poltash’s work dramatically accelerates the speed and reproducibility of mass spectrometry characterization, enabling unprecedented throughput in drug development. His achievements represent a paradigm shift from manual, labor-intensive processes to efficient, automated pipelines, directly impacting the speed at which life-saving biologic drugs can be developed and quality-controlled. This foundational work positions Dr. Poltash as a key architect of the next generation of analytical laboratories, where automation and high-throughput analysis are central to biotherapeutic innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
“Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics
24 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago